Calendar An icon of a desk calendar. Cancel An icon of a circle with a diagonal line across. Caret An icon of a block arrow pointing to the right. Email An icon of a paper envelope. Facebook An icon of the Facebook "f" mark. Google An icon of the Google "G" mark. Linked In An icon of the Linked In "in" mark. Logout An icon representing logout. Profile An icon that resembles human head and shoulders. Telephone An icon of a traditional telephone receiver. Tick An icon of a tick mark. Is Public An icon of a human eye and eyelashes. Is Not Public An icon of a human eye and eyelashes with a diagonal line through it. Pause Icon A two-lined pause icon for stopping interactions. Quote Mark A opening quote mark. Quote Mark A closing quote mark. Arrow An icon of an arrow. Folder An icon of a paper folder. Breaking An icon of an exclamation mark on a circular background. Camera An icon of a digital camera. Caret An icon of a caret arrow. Clock An icon of a clock face. Close An icon of the an X shape. Close Icon An icon used to represent where to interact to collapse or dismiss a component Comment An icon of a speech bubble. Comments An icon of a speech bubble, denoting user comments. Ellipsis An icon of 3 horizontal dots. Envelope An icon of a paper envelope. Facebook An icon of a facebook f logo. Camera An icon of a digital camera. Home An icon of a house. Instagram An icon of the Instagram logo. LinkedIn An icon of the LinkedIn logo. Magnifying Glass An icon of a magnifying glass. Search Icon A magnifying glass icon that is used to represent the function of searching. Menu An icon of 3 horizontal lines. Hamburger Menu Icon An icon used to represent a collapsed menu. Next An icon of an arrow pointing to the right. Notice An explanation mark centred inside a circle. Previous An icon of an arrow pointing to the left. Rating An icon of a star. Tag An icon of a tag. Twitter An icon of the Twitter logo. Video Camera An icon of a video camera shape. Speech Bubble Icon A icon displaying a speech bubble WhatsApp An icon of the WhatsApp logo. Information An icon of an information logo. Plus A mathematical 'plus' symbol. Duration An icon indicating Time. Success Tick An icon of a green tick. Success Tick Timeout An icon of a greyed out success tick. Loading Spinner An icon of a loading spinner.

Aberdeen Uni spin out set for next multi-million investment round

Post Thumbnail

A medical device company that spun out of the University of Aberdeen is on track to raise millions in a second round of funding from investors.

Sirakoss, which has developed synthetic bone graft technology, is seeking to raise between £3.5million to £5million this year to take its products through regulatory approvals in its key US and European markets. These regions along with Japan make up around 80% of the growing $3billion (£2.4billion) global orthopaedic market the firm targets with its products.

The firm, which spun out of the university in 2011, raised $4.8million (£3.8million) from a syndicate of investors led by Epidarex Capital, which included the Scottish Investment Bank, in 2014.

The company’s name is a cognate of “si” for silicon – a key components of its technology, “rak” – which comes from the Greek for spine and “os” for bone.

Brian Butchart, chief executive of Sirakoss, said the company was now headquartered in Edinburgh but that its research & development (R&D) heart was placed firmly in Aberdeen.

He said: “There’s a team of four in Aberdeen. The team is quite small overall, we are nine in total.

“We continue to see Aberdeen will be the focus of our R&D activities.”

One of the founders of the firm is Iain Gibson professor of biomaterials and regenerative medicine at University of Aberdeen and research and development (R&D) director of Sirakoss. Jordan Conway, the company’s R&D manager, also works in Aberdeen and has been with the firm since its early proof-of-concept days.

Mr Butchart, who joined the firm in 2009 to oversee the company’s commercial growth, said its next fundraising effort was “challenging” but demographics were working in the company’s favour.

“Raising funding is always a challenge in the UK for medical devices.

“But where pharmaceuticals are tens of millions to get through to this stage, for devices it is less than that. But it is still significant and that is why we will continue to raise investment funding.

“We will look for investment funding for second product development ranges in the next six months.”

He added: “People are getting to an age and they have a degenerative disease in their spine – that is only going to increase with an aging population.

“People are no longer happy to sit by the fire and say that is all they can do now. They want to be out golfing, fishing, sailing.

“There is a positive social impact if people can stay active – and an economic impact.

“We are seeing a growth in these procedures worldwide.”

Already a subscriber? Sign in

[[title]]

[[text]]